Health economic studies are gaining importance to demonstrate value to payers, providers and decision makers. It is a key challenge to communicate health economic study design and outcomes to non-experts.
Even state of the art HEOR studies face difficulties of acceptance and have a lower than expected impact on decision makers. The pay off of HEOR investments is not reaching its full potential.
Clients are seeking ways to leverage HEOR studies to accelerate market access and market uptake.
pharmaLevers is helping clients to:
- translate pharmacoeconomic results into the payer and decision makers perspective
- interpretation of health economic models
- creation of health economic and pharmacoeconomic models